NCI Events
Featured Event
Translational Advances in Cancer Prevention Agent Development (TACPAD) – 2nd Biennial Virtual Meeting
Event Date: September 7, 2022
The main goals of the meeting are to: 1) Foster the exchange of ideas & potentially new collaborative interactions among leading cancer prevention researchers from basic & clinical research, 2) Highlight new & emerging trends in immunoprevention & chemoprevention as well as new information from clinical trials, & 3) Inform the research community of the significant resources available from NCI.
Need an Event Site?
CBIIT can assist you with building an event website hosted here at events.cancer.gov. Event websites include customized registrations, agendas, abstracts, speaker bios, and surveys. Event organizers have direct access to the information with the ability to edit content, export registration data and request automated email reminders. Site builds take a minimum of three weeks and all forms must have OMB clearance. Use the link below to request an event site.
Upcoming Events
(Displaying 13 out of 13 results)August 2022
NCI Emerging Technologies Seminar Series (Event)
Event Date: August 23, 2022 Virtual Event
This seminar series will highlight novel technologies that could transform cancer research and clinical care. These virtual monthly seminars will each showcase an innovative technology from an NCI-supported investigator, including the challenges and opportunities of technology development and how the tools can be used to advance cancer research. The seminar occurs at the end of every month on a Tuesday at 2:00pm ET and is held through Zoom.
Junior Investigator Meeting
Event Date: August 25, 2022 Hybrid Event
This 2-day meeting will bring together junior investigators (defined as late stage graduate students, postdocs, and early career faculty) representing experimental and systems biologists, physical scientists, big data scientists, and computational modelers who build and apply novel tools to better understand cancer.
NCORP Annual Meeting
Event Date: August 25, 2022 Hybrid Event
The NCI Community Oncology Research Program (NCORP) is a NCI-supported network that brings cancer treatment, prevention, control, and cancer care delivery research (CCDR) trials to people in their communities.
Novel Chemical Approaches for Targeting Fusion Oncoproteins Webinar Series
Event Date: August 26, 2022 Webinar Event
The goal of this webinar series is to enhance understanding within the NCI and the research community of opportunities for targeting fusion oncoproteins through emerging chemoproteomic methods. This Webinar Series is being held virtually on Fridays at noon ET on the following dates: August 19, August 26, September 9, September 16, September 23, September 30, October 7, October 14, and October 21.
September 2022
Translational Research in Clinical Oncology (TRACO)
Event Date: September 6, 2022 WebEx Event
TRACO is designed to provide an overview of general principles of cancer biology and treatment, epidemiology, genomics, precision medicine, mechanisms of resistance, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology and meet leaders in cancer research. The participation of NIH Postdoctoral and Clinical Fellows is encouraged.
Translational Advances in Cancer Prevention Agent Development (TACPAD) – 2nd Biennial Virtual Meeting
Event Date: September 7, 2022 Virtual Event
The main goals of the meeting are to: 1) Foster the exchange of ideas & potentially new collaborative interactions among leading cancer prevention researchers from basic & clinical research, 2) Highlight new & emerging trends in immunoprevention & chemoprevention as well as new information from clinical trials, & 3) Inform the research community of the significant resources available from NCI.
Cancer Target Discovery and Development (CTD²) Network Annual Meeting (Event)
Event Date: September 20, 2022 Hybrid Event
The Cancer Target Discovery and Development (CTD²) Network annual face-to-face meeting is organized by the Center for Cancer Genomics (CCG) at the National Cancer Institute (NCI). The hybrid meeting, with in-person and virtual options available, will be held on September 20, 2022 at the Broad Institute in Cambridge, Massachusetts.
Fall 2022 NCI Early Drug Development
Event Date: September 22, 2022 WebEx Event
The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel involved in CTEP funded oncology early drug development (e.g. nurses, statisticians, translational scientist, etc.) The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.
Human Carcinogenesis & Health Disparity Meeting
Event Date: September 29, 2022 In-person (NIH Campus) & Virtual
This scientific symposium is an in-person/virtual (hybrid) two-day meeting with keynote addresses delivered by distinguished LHC scientific advisors, NCI collaborators, current and alumni LHC research staff. This symposium presents an opportunity to hear the latest research in the field of carcinogenesis from notable leaders in the field.
October 2022
Animal Models for Cancer Interception and Precision Prevention Virtual Workshop
Event Date: October 13, 2022 Virtual Event
This 2-day virtual workshop will inform the scientific community about the current status of cancer interception and precision prevention animal models, highlight new and emerging trends in model development, and identify and propose the means to address unmet translational requirements/needs.
NCI Alliance for Nanotechnology in Cancer Annual Principal Investigator Meeting
Event Date: October 18, 2022 Virtual Event
The 2022 NCI Alliance for Nanotechnology in Cancer Annual Principal Investigator Meeting will be held virtually on October 18-19, 2022. The meeting will gather the Alliance investigators and collaborators to present their recent research results as well as to discuss emerging opportunities in cancer nanotechnology.
18th International Conference on Malignancies in HIV/AIDS (ICMH)
Event Date: October 24, 2022 In Person Event
You are invited to join us at the 18th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). The meeting will take place October 24-25, 2022, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.
November 2022
2022 NCI Cohort Consortium Virtual Annual Meeting
Event Date: November 1, 2022 Virtual Event
This two day virtual event is sponsored by the Division of Cancer Control and Population Sciences (Epidemiology and Genomics Research Program) and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), with a goal to bring together consortium researchers to discuss emerging science, scientific progress of consortium projects and groups, gaps and opportunities for collaboration across studies, and ideas for new scientific projects in the consortium.